Qube Research & Technologies LTD United Therapeutics Corp Transaction History
Qube Research & Technologies LTD
- $91.4 Billion
- Q3 2025
A detailed history of Qube Research & Technologies LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 29,599 shares of UTHR stock, worth $13.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,599
Previous 151,095
80.41%
Holding current value
$13.8 Million
Previous $43.4 Million
71.42%
% of portfolio
0.01%
Previous 0.05%
Shares
25 transactions
Others Institutions Holding UTHR
# of Institutions
803Shares Held
41.4MCall Options Held
1.56MPut Options Held
2.86M-
Black Rock Inc. New York, NY5.47MShares$2.55 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$2.06 Billion0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.17MShares$1.01 Billion1.29% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$943 Million11.58% of portfolio
-
State Street Corp Boston, MA1.92MShares$897 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $21.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...